首页> 外文期刊>Cancer Growth and Metastasis >Serum YKL-40 Levels in Patients with Esophageal Squamous Cell Carcinoma
【24h】

Serum YKL-40 Levels in Patients with Esophageal Squamous Cell Carcinoma

机译:食管鳞状细胞癌患者血清YKL-40水平

获取原文
           

摘要

Aims and background: YKL-40 is a glycoprotein secreted by macrophages, neutrophils and malignant tumor cells. YKL-40 is expressed and secreted by several types of tumors. The aim of this study examined the clinical usefulness of YKL-40 for detection in esophageal squamous cell carcinoma (ESCC).Methods: Using ELISA kits, we measured the concentration of YKL-40 in serum from 100 patients with ESCC and compared this concentration with healthy population.Results: We found significantly higher serum levels of YKL-40 in patients with ESCC compared to the healthy population (P < 0.0001).Conclusions: These results suggested that regarding serum YKL-40 as a tumor marker could be benefical in the early clinical diagnosis.
机译:目的和背景:YKL-40是一种由巨噬细胞,嗜中性粒细胞和恶性肿瘤细胞分泌的糖蛋白。 YKL-40由几种类型的肿瘤表达和分泌。本研究的目的是检验YKL-40在食管鳞状细胞癌(ESCC)检测中的临床实用性。方法:使用ELISA试剂盒,我们测量了100例ESCC患者血清中YKL-40的浓度,并将其与结果:我们发现ESCC患者的YKL-40血清水平明显高于健康人群(P <0.0001)。结论:这些结果表明,将血清YKL-40作为肿瘤标志物可能对患者有益。早期临床诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号